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Under steady-state approximately 70% of the hematopoietic 
stem and progenitor cells (HSPC) in the bone marrow are 
quiescent, with low metabolic activity fueled by glycolytic 
metabolites (1). However, in response to exogenous 
demands such as cell loss or damage, or infection, they 
become highly proliferative and can efficiently and quickly 
expand or reconstitute the blood and immune systems (2,3). 
Stem and progenitor cell activation and proliferation relies 
primarily on mitochondrial oxidative phosphorylation (4). 
Intracellular reactive oxygen species (ROS) are a by-
product of mitochondrial oxidative phosphorylation that are 
generated by the respiratory chain primarily in the form of 
superoxide anions (O2
−) and are immediately transformed by 
mitochondrial superoxide dismutase (MnSOD) to hydrogen 
peroxide (H2O2) (5). HSPCs are highly sensitive to ROS 
and under normal physiological condition; ROS levels are 
tightly regulated to prevent hematopoietic cell damage 
(6-8). Accumulating evidence indicates that the inability 
to regulate high levels of ROS can lead to impaired stem 
and progenitor cell homeostasis and bone marrow failure 
(6-9). Evidence also suggest a role for chronic oxidative 
stress in the progression of radiation-induced acute and 
late hematopoietic syndromes (10,11), stem cell aging 
and (12) degenerative diseases (13), whereas ROS scavengers 
improve HSPC function and engraftment (9,14). Recently, 
genetic deletion of the core DNA damage response 
transcription factor Atm identified supra-physiological 
elevation of ROS as a key mediator of stem cell exhaustion, 
shorter lifespan and premature aging (6). However, to date, 
there has been little compelling molecular mechanisms 
that link this unrelated gene mutation to detrimental 
intracellular accumulation of ROS. 
Chronic exposure to type 1 interferon (IFN-1), a 
primary effector cytokine against viral infection, can cause 
hematopoietic stem cells to exit quiescence and induces 
extensive stem cell proliferation that can lead to functional 
defects (2,15). IFN-1 signaling increases phosphorylation of 
signal transducer and activator of transcription 1 (STAT-1) 
and the serine/threonine-specific protein kinase B, Akt, 
which enhance expression of IFN-1 target genes and lead 
to cell cycle progression in HSPCs (2). Thus, even though 
associations between IFN-1 signaling and deficiencies in 
stem and progenitor cell function have been established, 
the molecular events linking IFN-1 signaling and defects 
in hematopoietic cell function are not well understood. In a 
recent issue of Cell Stem Cell, an elegant study by Tasdogan 
and co-workers (16) demonstrates that chronic activation 
of INF-1 signaling as a consequence of DNA damage 
mobilizes mitochondrial Bid resulting in exaggerated 
intracellular accumulation of ROS that leads to functional 
defects in HSPCs, thus establishing a novel role for IFN-
1 and Bid cross talk in hematopoietic cell function. To 
identify factors/mechanisms involved in the DNA damage 
response that mediate altered hematopoietic function, 
the group performed functional analysis of HSPCs 
in Mll5−/− mice with inherited inefficient DNA repair 
machinery. In this model, massive DNA damage, excessive 
cell-cycle and elevated ROS were detected in all major 
subpopulations of lineage negative, Sca-1 positive, c-kit 
positive (LSK) cells, the population of mouse cells that 
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contain stem and progenitor cells, whereas treatment with 
the radical scavenger N-acetyl-L-cysteine (NAC) resulted 
in substantial reduction of ROS in these cells and effective 
correction of the hematopoietic deficits in Mll5−/− mice. 
Analysis in Mll5−/− and IFNar1−/− double-deficient mice, 
lacking both effective DNA repair and IFN-1 receptor 
signaling provided conclusive evidence that exaggerated 
ROS accumulation and HSPC functional abnormalities in 
Mll5−/− mice are primarily due to chronic activation of IFN-
1 signaling. Further studies pointed to the involvement of 
mitochondria in the accumulation of ROS in HSPCs, as 
Mll5−/− HSPC exhibited increased mitochondrial membrane 
potential and elevated levels of intra-mitochondrial ROS. 
Higher mitochondrial ROS in Mll5−/− mice was correlated 
with substantial mitochondrial accumulation of full length 
Bid, which has previously been identified as an inducer 
of mitochondrial ROS and a key player in preserving 
hematopoietic cell function (17,18). Genetic deletion of Bid 
in Mll5−/− mice revealed 90% reduction in supra-natural 
ROS in HSPC and improved key hematopoietic anomalies 
including long-term repopulation ability of HSCs and 
hyper-proliferation of HSPC. Furthermore, lack of IFNar1 
signaling resulted in substantial lower levels of full-length 
Bid and ROS in mitochondria and substantially improved 
hematopoiesis in Mll5−/− mice. Taken together, these novel 
findings identify that supra-natural mitochondrial ROS 
accumulation in response to IFN-1 signaling-mediated 
Bid mobilization plays a key role in hyper-proliferation 
and function of HSPCs. These findings have critical 
implications for understanding the mechanisms that 
promote malignant transformation and aging of blood stem 
and progenitor cells where the DNA damage response is 
compromised and offers exciting therapeutic opportunities 
by which the manipulation of Bid mobilization and 
ROS levels in stressed hematopoiesis, such as during 
inflammation, radiation exposure, aging and malignant 
transformation, may preserve normal hematopoiesis.
While mitochondrial BID mobilization appears to be the 
central culprit for toxic accumulation of ROS and altered 
function of HSPCs in response to DNA damage, several 
questions remain. A key question is how does mitochondrial 
Bid mobilization translate into toxic accumulation of ROS? 
It is possible that Bid modulates mitochondrial ROS levels 
by interaction with its receptor, mitochondrial carrier 
homolog 2 (MTCH2). MTCH2 is a surface-exposed outer 
mitochondrial membrane protein that is important for Fas-
induced liver apoptosis (19). In addition, MTCH2 is also 
identified in a genome-wide association study as a new 
gene locus associated with body mass index in humans (19). 
Thus, MTCH2 may also be involved in regulating 
mitochondrial metabolism. Another key question will be to 
determine whether chronic IFN-1 signaling-mediated Bid 
mobilization switches metabolism in hematopoietic stem 
cells from glycolysis to oxidative phosphorylation and how 
this is accomplished. Indeed, IFN-1 signaling can enhance 
oxidative phosphorylation in plasmacytoid dendritic cell 
and non-hematopoietic cells in response to the Toll-like 
receptor-9 agonist CpGA (20). In addition, because Mll5 
is expressed in human cells (21) and mutation in this gene 
has been implicated in acute myeloid leukemia (AML) and 
myeloproliferative disease (22) and positively associated 
with elevated ROS accumulation in (AML) cells, it would be 
clinically relevant to explore whether mutation in the Mll5 
gene disrupts DNA repair machinery that leads to IFN-1 
signaling, Bid mobilization and ROS accumulation in AML 
patients. 
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